BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1832982)

  • 1. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation.
    Sands JM; Neylan JF; Olson RA; O'Brien DP; Whelchel JD; Mitch WE
    J Am Soc Nephrol; 1991 Mar; 1(9):1081-6. PubMed ID: 1832982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation.
    Gianello P; Carlier M; Jamart J; Hulhoven R; Bernheim J; Bernard A; Ketelslegers JM; Squifflet JP
    Clin Transplant; 1995 Dec; 9(6):481-9. PubMed ID: 8645892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous infusion of atriopeptin 3 on immediate renal allograft function.
    Ratcliffe PJ; Richardson AJ; Kirby JE; Moyses C; Shelton JR; Morris PJ
    Kidney Int; 1991 Jan; 39(1):164-8. PubMed ID: 1825857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of alpha-human atrial natriuretic peptide on the incidence of acute renal failure in cadaveric kidney transplantation.
    Smits P; Huysmans F; Hoitsma A; Tan A; Koene R
    Transpl Int; 1989 Aug; 2(2):73-7. PubMed ID: 2528962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma atrial natriuretic factor and graft function in renal transplant recipients.
    Raine AE; Anderson JV; Bloom SR; Morris PJ
    Transplantation; 1989 Nov; 48(5):796-800. PubMed ID: 2530666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
    Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P
    Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of the ANF analog A68828 on recovery from ischemic acute renal failure.
    Pollock DM; Opgenorth TJ
    Ren Fail; 1992; 14(2):141-6. PubMed ID: 1386156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial.
    Swärd K; Valsson F; Odencrants P; Samuelsson O; Ricksten SE
    Crit Care Med; 2004 Jun; 32(6):1310-5. PubMed ID: 15187512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic factor improves renal function and lowers systolic blood pressure in renal allograft recipients treated with cyclosporin A.
    Lang CC; Henderson IS; Mactier R; Stewart WK; Struthers AD
    J Hypertens; 1992 May; 10(5):483-8. PubMed ID: 1317909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure.
    Pollock DM; Opgenorth TJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1166-9. PubMed ID: 2148187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Gnädinger MP; Shaw S; Suchecka-Rachon K; Saxenhofer H
    Am J Nephrol; 1989; 9(4):291-9. PubMed ID: 2530903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma human atrial natriuretic factor in cirrhosis and ascites with and without functional renal failure.
    Morgan TR; Imada T; Hollister AS; Inagami T
    Gastroenterology; 1988 Dec; 95(6):1641-7. PubMed ID: 2972583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance.
    Lang CC; Moreland T; Choy AM; Pringle TH; McNeill GP; Struthers AD
    Eur J Clin Pharmacol; 1995; 48(6):429-34. PubMed ID: 8582459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of leg vascular tissues to the overall metabolic clearance of human atrial natriuretic factor (hANF) in man.
    Gasic S; Vierhapper H; Nowotny P; Heinz G; Waldhäusl W
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):113-5. PubMed ID: 1830036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K; Valsson F; Sellgren J; Ricksten SE
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of the natriuretic peptide ularitide in acute renal failure.
    Meyer M; Pfarr E; Schirmer G; Uberbacher HJ; Schöpe K; Böhm E; Flüge T; Mentz P; Scigalla P; Forssmann WG
    Ren Fail; 1999 Jan; 21(1):85-100. PubMed ID: 10048120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.
    Goggins WC; Pascual MA; Powelson JA; Magee C; Tolkoff-Rubin N; Farrell ML; Ko DS; Williams WW; Chandraker A; Delmonico FL; Auchincloss H; Cosimi AB
    Transplantation; 2003 Sep; 76(5):798-802. PubMed ID: 14501856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of single and paired pediatric kidneys into adult recipients.
    Ratner LE; Cigarroa FG; Bender JS; Magnuson T; Kraus ES
    J Am Coll Surg; 1997 Nov; 185(5):437-45. PubMed ID: 9358086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.